Skip to main content
Home

Search form

  • ABOUT US
    • ECFS Society Details
      • Society Information
      • Applications for Support
    • ECFS Membership
      • Membership Subscription
      • Membership Demographics
    • Other Information
      • Latest News
      • Job Opportunities
      • Grants and Programmes
      • Links
  • RESEARCH
    • ECFS Projects
      • ECFS Clinical Trials Network
      • ECFS Patient Registry
    • ECFS Working Groups
      • Diagnostic Network
      • Exercise
      • Neonatal Screening
      • Fungal Pathogens
      • Pulmonary Exacerbation
    • Special Projects
      • ECFS / CF Europe Post-Doctoral Research Fellowship
      • CFQ-R questionnaire and CF candidates for lung transplant
      • EU funded projects
      • MucoFong International Project
      • Complete CFTR gene mutation analysis in European patients with Cystic Fibrosis
    • Past Working Groups
      • Cystic Fibrosis Molecular and Cell Biology and Physiology Basic Science
      • ECFS Gene Modifier Working Group
      • ECFS Non Tuberculous Mycobacteria Working Group
  • CARE
    • ECFS Standards Of Care
    • ECFS Working Groups
      • Exercise
      • Diagnostic Network
      • Neonatal Screening
      • Mental Health
      • Fungal Pathogens
      • Pulmonary Exacerbation
      • Telehealth
    • Allied Health Professionals
      • ECFS Nursing Special interest Group
      • European CF Pharmacy Group
      • European Cystic Fibrosis Nutrition Group
      • European Psychosocial Special Interest Group
      • ECFS Physiotherapy Special Interest International Group
  • EDUCATION
  • CONFERENCES & EVENTS
    • European Cystic Fibrosis Conference
    • ECFS Basic Science Conference
    • Related events
    • Past ECFS conferences
  • PUBLICATIONS
    • About Publications
      • The Journal of Cystic Fibrosis
      • ECFS Newsletter
      • ECFS Book
      • ERS Monograph
    • Resources
      • Search All Resources
      • CF Research News
      • Consensus Reports
      • ECFS Guidelines
      • Free Access Articles
      • CF Literature
  • MEMBERSHIP
  • LOG IN

Other Guidelines

Evaluating Fertility Preservation Telehealth Counseling for Males with Cystic Fibrosis

  • Read more about Evaluating Fertility Preservation Telehealth Counseling for Males with Cystic Fibrosis

How Personalized Genetic Testing for Medication Metabolism May Reduce Problems with Medications for People with Cystic Fibrosis

  • Read more about How Personalized Genetic Testing for Medication Metabolism May Reduce Problems with Medications for People with Cystic Fibrosis

11-year evaluation of newborn screening for Cystic Fibrosis in Switzerland

  • Read more about 11-year evaluation of newborn screening for Cystic Fibrosis in Switzerland

In-depth examination of the CFTR gene finds more disease-causing genetic changes than conventional clinical genetic testing

  • Read more about In-depth examination of the CFTR gene finds more disease-causing genetic changes than conventional clinical genetic testing

Presentation of two siblings with CF born to a mother with CF taking Trikafta (Kaftrio) throughout both pregnancies. A baby boy has normal vas deferens after birth.

  • Read more about Presentation of two siblings with CF born to a mother with CF taking Trikafta (Kaftrio) throughout both pregnancies. A baby boy has normal vas deferens after birth.

Could glucose tolerance tests used to detect cystic fibrosis related diabetes be performed at home?

  • Read more about Could glucose tolerance tests used to detect cystic fibrosis related diabetes be performed at home?

Lung function and imaging outcomes in children with cystic fibrosis diagnosed after newborn screening

  • Read more about Lung function and imaging outcomes in children with cystic fibrosis diagnosed after newborn screening

Do adult patients with cystic fibrosis suffer from sexual dysfunction?

  • Read more about Do adult patients with cystic fibrosis suffer from sexual dysfunction?

Exercise capacity after one year of Kaftrio® treatment in people with Cystic Fibrosis

  • Read more about Exercise capacity after one year of Kaftrio® treatment in people with Cystic Fibrosis

Modulatory therapy discontinuation of children with cystic fibrosis

  • Read more about Modulatory therapy discontinuation of children with cystic fibrosis
  • first
  • previous
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • next
  • last
Terms & Conditions Privacy policy  Accessibility Sitemap Contact 
© EUROPEAN CYSTIC FIBROSIS SOCIETY 2025. All rights reserved. Website by VidaVia (link is external)
European Cystic Fibrosis Society (ECFS)